Profile picture

Associate Professor Michal Mazurek

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)
Membership: FESC Member EHRA Member HFA Member
Follow
Biography
- Practicing electrophysiologist (Silesian Centre for Heart Diseases, Zabrze, Poland, http://www.sccs.pl/en/) - EHRA Young EP Ambassador for Poland - EHRA Scientific Initiatives Committee (SIC) member - Secretary of the Polish Heart Rhythm Society - Past Chairperson of the Katowice Division of the Polish Cardiac Society - UK Foundation Programme graduate - University of Cambridge - Fellowship on atrial fibrillation at the University of Birmingham Main research interest: 1. Conduction system pacing (CSP) 2. Implantable devices (pacemakers, in particular CSP, ICDs, CRT, LOT-CRT) 3. Heart failure 4. Atrial fibrillation, atrial and ventricular arrhythmias 5. Ablation (both supra- and ventricular arrhythmias) Languages: 1. Polish 2. English 3. German Hobby: 1. Football 2. Bike
Logo ESC

Contributor content

Conduction system pacing vs biventricular pacing vs optimized cardiac resynchronization therapy (LOT-CRT) for heart failure patients
Presentation
Conduction system pacing vs biventricular pacing vs optimized cardiac resynchronization therapy (LOT-CRT) for heart failure patients
Baseline creatinine level and long-term outcomes in patients with heart failure undergoing cardiac resynchronization therapy
Presentation
Baseline creatinine level and long-term outcomes in patients with heart failure undergoing cardiac resynchronization therapy
Long-term outcome and mortality predictors in patients with extremely enlarged left ventricle end-diastolic diameter undergoing cardiac resynchronization therapy
Presentation
Long-term outcome and mortality predictors in patients with extremely enlarged left ventricle end-diastolic diameter undergoing cardiac resynchronization therapy
10-year survival in patients undergoing cardiac resynchronization therapy
Presentation
10-year survival in patients undergoing cardiac resynchronization therapy
10-year outcomes of triple-site versus standard cardiac resynchronization therapy randomized trial (TRUST CRT)
Presentation
10-year outcomes of triple-site versus standard cardiac resynchronization therapy randomized trial (TRUST CRT)
Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry
Presentation
Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry
Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry
Presentation
Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry

ESC 365 is supported by